Somaxon makes big entry into competitive arena: insomnia drug will push Neurocrine for $2.5 billion market.
San Diego Business Journal › June 20, 2005
Linked as:
Extract
Somaxon makes big entry into competitive arena: insomnia drug will push Neurocrine for $2.5 billion market.
San Diego-based Somaxon Pharmaceuticals Inc. didn't waste any time putting its recently raised $65 million in venture capital financing to use.
The San Diego-based specialty pharmaceutical company ...See the full content of this document
Sponsored links
